Related references
Note: Only part of the references are listed.Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model
David W. Hawman et al.
NATURE MICROBIOLOGY (2021)
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
Martin F. Bachmann et al.
NPJ VACCINES (2021)
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
Rebecca L. Brocato et al.
NPJ VACCINES (2021)
Inactivation of SARS-CoV-2 Laboratory Specimens
Elaine Haddock et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice
Kaihao Feng et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan et al.
CELL (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Immunization of turkeys with a DNA vaccine expressing the haemagglutinin gene of low pathogenic avian influenza virus subtype H9N2
Awad A. Shehata et al.
JOURNAL OF VIROLOGICAL METHODS (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
T cells in COVID-19-united in diversity
Leo Swadling et al.
NATURE IMMUNOLOGY (2020)
Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China
Xiaoyan Zheng et al.
VIROLOGY JOURNAL (2020)
Multivalent nanomedicines to treat COVID-19: A slow train coming
Tanveer A. Tabish et al.
NANO TODAY (2020)
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber et al.
NATURE COMMUNICATIONS (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
DNA VaccinesHow Far From Clinical Use?
Dominika Hobernik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Polyethylenimine-based micro/nanoparticles as vaccine adjuvants
Chen Shen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
POLYMER NANOPARTICLES Weighing up gene delivery
Ameya R. Kirtane et al.
NATURE NANOTECHNOLOGY (2013)
Tolerability of intramuscular and intradermal delivery by CELLECTRA® adaptive constant current electroporation device in healthy volunteers
Malissa C. Diehl et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
Byoung-Shik Shim et al.
BMC IMMUNOLOGY (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization
CL Densmore et al.
MOLECULAR THERAPY (2000)
Share Paper
